Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chelimsky-Fallick

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The American Journal of Cardiology|October 15, 1995
Excessive oxygen deficit during low-level exercise in heart failureC Chelimsky-Fallick, L W Stevenson, V Lem, et al.
The American Journal of Cardiology|December 1, 1990
Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathyL W Stevenson, J H Tillisch, M Hamilton, et al.
Circulation|August 19, 1997
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failureA E Steimle, L W Stevenson, C Chelimsky-Fallick, et al.
Journal of the American College of Cardiology|March 15, 1992
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trialG C Fonarow, C Chelimsky-Fallick, L W Stevenson, et al.
Circulation|November 1, 1992
Modeling distribution of donor hearts to maximize early candidate survivalL W Stevenson, S L Warner, M A Hamilton, et al.
Journal of the American College of Cardiology|December 1, 1992
Amiodarone therapy does not compromise subsequent heart transplantationC Chelimsky-Fallick, H R Middlekauff, W G Stevenson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The American Journal of Cardiology|October 15, 1995
Excessive oxygen deficit during low-level exercise in heart failureC Chelimsky-Fallick, L W Stevenson, V Lem, et al.
The American Journal of Cardiology|December 1, 1990
Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathyL W Stevenson, J H Tillisch, M Hamilton, et al.
Circulation|August 19, 1997
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failureA E Steimle, L W Stevenson, C Chelimsky-Fallick, et al.
Journal of the American College of Cardiology|March 15, 1992
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trialG C Fonarow, C Chelimsky-Fallick, L W Stevenson, et al.
Circulation|November 1, 1992
Modeling distribution of donor hearts to maximize early candidate survivalL W Stevenson, S L Warner, M A Hamilton, et al.
Journal of the American College of Cardiology|December 1, 1992
Amiodarone therapy does not compromise subsequent heart transplantationC Chelimsky-Fallick, H R Middlekauff, W G Stevenson, et al.
Pageof 1